• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.

Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome. Thromb Haemost. 2010 Nov; 104(5):976-83.

View in: PubMed

subject areas
  • Acute Coronary Syndrome
  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Blood Coagulation
  • Chi-Square Distribution
  • Chromatography, Liquid
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Down-Regulation
  • Enzyme-Linked Immunosorbent Assay
  • Factor Xa
  • Factor Xa Inhibitors
  • Female
  • Fibrin Fibrinogen Degradation Products
  • Fibrinolytic Agents
  • Humans
  • International Normalized Ratio
  • Male
  • Middle Aged
  • Odds Ratio
  • Partial Thromboplastin Time
  • Peptide Fragments
  • Placebo Effect
  • Prothrombin
  • Pyrazoles
  • Pyridones
  • Tandem Mass Spectrometry
  • Thrombin
  • Time Factors
  • Treatment Outcome

authors with profiles
  • Robert Harrington